UK Drug Strategy 2010 Evaluation Framework – Evaluating costs and benefits

Publications

UK Drug Strategy 2010 Evaluation Framework – Evaluating costs and benefits

15 January 2014

The Home Office report is called 'Drug Strategy 2010 Evaluation Framework – evaluating costs and benefits'. It is not the sort of title which seduces the attention, but inside you can find a fascinating, topsy-turvy, down-the-looking-glass world of hopeless causes.

The Government’s Drug Strategy 2010‘Reducing Demand, Restricting Supply, Building Recovery: Supporting people to live a drug free life’,made a commitment to develop an evaluation framework to assess its effectiveness and value for money (VfM).

On its own, that's a creditable aim. The more we look into the spending on anti-drug programmes the more we highlight the chasm of financial and human waste which constitutes prohibition.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.